ISSN: 2476-2075

検眼: オープンアクセス

オープンアクセス

当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い

オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得

抽象的な

The effect of heat treatment on Meibomian Gland Dysfunction

Srihari Narayanan, Sandra Fortenberry, Narges Kasraie, Charles G Connor

Objective: Meibomian gland dysfunction (MGD) is the most common cause of dry eye disease (DED). Though manual warm compresses (WC) are the backbone of managing MGD, poor compliance makes an office-based procedure desirable. This paper compares WC to MiBoFlo and the heated eye pad. MiBoFlo uses a thermoelectric heat pump to deliver a constant level of heat through an ultrasound gel. Digital Heat Inc developed an electric powered Heated Eye Pad (HEP) designed to warm the Meibomian sebum. The HEP resembles a spectacle frame.

Methods: Sixty subjects with MGD were randomly divided into three treatment groups after collection of baseline data. Baseline data included Ocular Surface Disease Index (OSDI), Tear Break-up time (TBUT) and Efron grading of MGD and blepharitis. The same data were collected 4 weeks after treatment. The first group was the warm compress group, the second group the MiBoFlo group and the third group the heated eye pad.

Results: Only the warm compress group showed statistically significant reduction in dry eye symptoms by OSDI (p=0.015) but the other two techniques did reduce symptoms from baseline. None of the techniques improved TBUT from baseline in a statistically significant manner. The MiBoFlo was the only treatment that resulted in a statistically significant change from baseline in Efron grading of both MGD (p=0.01) and blepharitis (p=0.01).

Conclusion: Our data suggests that MiBoFlo and the heated eye pad may be suitable alternatives to WC to achieve greater patient compliance.